Biopreservation Market Synopsis and Highlights, Key Findings, Major Companies Analysis and Forecast to 2030
Biopreservation
Market Size & Trends
The global biopreservation market size was valued
at USD 2.18 billion in 2022 and is projected to grow at a compound
annual growth rate (CAGR) of 28.30% from 2023 to 2030.
Biopreservation is experiencing growth due to various factors such
as extensive usage in hospitals and labs, rising funding assistance from
government and private partners in healthcare, an upsurge in research &
development, and growing advancement in terms of product development. For
example, in April 2021, BioLife Solutions launched a new high-capacity
controlled freezer to cater to the cell and gene therapy market, which helped
the company expand its existing product portfolio. The market experienced a
major hindrance during the COVID-19 pandemic with supply chain issues,
unavailability of raw materials, and hindrances in research activities among
other reasons. However, the pandemic also accelerated the growth of novel
biologics, and vaccine technologies. Due to these factors, opportunities for
biologics manufacturing and preservation are anticipated to increase, thus
generating further demand for biopreservation.
Gather more insights about the market drivers, restrains and
growth of the Biopreservation
Market
Biopreservation is a process that helps maintain the integrity and
functionality of biological products such as stem cells, DNA, tissues, and
organs under different temperatures, thereby prolonging their lifespan outside
their natural environment. Technology innovations
include microarrays or incorporation of a wide range of predictive
models, such as hybrid models, and various API algorithms which help reduce the
time, cost and complexity of the overall process. Furthermore, the advent of
multiplex cellular imaging platforms is anticipated to enhance the
biopreservation ability to help understand disease progression and suggest
suitable diagnostic & treatment measures to follow, specifically for
cardiology, gynecology, and point-of-care applications.
In recent years, there has been an upsurge in demand for use of
biopreservation to develop biological products in R&D of various sectors
such as immunotherapies, vaccine production, antibody production, enzyme
technology, and biologically produced chemicals. This impact is due to the
rising number of chronic disease incidences globally. For instance, according
to the Centers for Disease Control and Prevention, cardiovascular disorders and
cancer are among the leading causes of disease-related mortality in adults in
the U.S.
Furthermore, the government and private sectors have shown
interest and supported funding activities in research & development,
leading to immense market developments. In recent years, the growing demand for
preserving stem cells and developing biological medicines and products has
gained investors' focus in this field. This considerable healthcare spending is
expected to fuel market growth during the forecast period.
However, the growing biopreservation market is associated with
challenges such as the unavailability of skilled professionals and the lack of
stringent cybersecurity measures. The high cost of labor training and software
standardization are some of the contributing factors. These challenges could
potentially impact overall market growth.
Biopreservation
Market Segmentation
Grand View Research has
segmented the global biopreservation market report on the basis of product,
application, and region:
Product Outlook (Revenue, USD Billion, 2018 - 2030)
·
Equipment
·
Freezers
·
Refrigerators
·
Consumables
·
Vials
·
Straws
·
Microtiter Plates
·
Bags
·
Liquid Nitrogen
·
Media
·
Pre-formulated
·
Home-brew
·
Laboratory Information Management System (LIMS)
Application Outlook (Revenue, USD Billion, 2018 - 2030)
·
Regenerative Medicine
·
Cell Therapy
·
Gene Therapy
·
Others
·
Bio-banking
·
Human Eggs
·
Human Sperms
·
Veterinary IVF
·
Drug Discovery
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
·
US
·
Canada
Europe
·
Germany
·
UK
·
France
·
Italy
·
Spain
·
Denmark
·
Sweden
·
Norway
Asia Pacific
·
China
·
Japan
·
India
·
Australia
·
Thailand
·
South Korea
Latin America
·
Brazil
·
Mexico
·
Argentina
Middle East
and Africa (MEA)
·
South Africa
·
Saudi Arabia
·
UAE
·
Kuwait
Browse through Grand View Research's Biotechnology
Industry Research Reports.
The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at
a CAGR of 26.76% from 2024 to 2030.
The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a
CAGR of 3.8% from 2024 to 2030.
Key Companies & Market Share Insights
Key players in the market are opting for strategic initiatives,
funding facilities for geographical expansion, partnerships, mergers and
acquisitions in key regions. For instance, in January 2023, the Hamad Medical
Corporation and Qatar BioBank launched a new tissue biobank service in Qatar to
provide researchers the access to high-quality tissue samples. Some of the key
players in the biopreservation market include:
·
Azenta US, Inc.
·
Biomatrica, Inc.
·
BioLife Solutions
·
MVE Biological Solutions
·
LabVantage Solutions, Inc.
·
Taylor-Wharton.
·
Thermo Fisher Scientific, Inc.
·
Panasonic Corporation
·
X-Therma Inc.
·
PrincetonCryo.
·
Stirling Ultracold
Order
a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand
View Research.
Comments
Post a Comment